Uni-Graft® K DV Patch is marketed in Europe since 1999 for reconstructive interventions of the deep femoral, femoral and iliac artery and was also indicated for carotid interventions until 01/2020. Previous studies focused on the clinical performance of different patch materials used for patch angioplasty in different indications, without specifying the product or manufacturer. Thus, it is not surprising that there is a limited amount of published literature available describing the use of the Uni-Graft® K DV Patch in the clinical routine. Therefore, the aim of the present non-interventional study (NIS) is to close this gap by collecting and evaluating existing safety and performance data documented in the clinical routine especially during the application of the Uni-Graft® K DV Patch.
Study Type
OBSERVATIONAL
Enrollment
200
Vascular reconstructions in the carotid, profunda, femoral and iliac arteries
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Restenosis Rate in postoperative Course
Retrospective evaluation of restenosis rate from information documented in the patient file: the NASCET is an angiographic measurement recommended by the "North American Symptomatic Carotid Endarterectomy Trial"-Group. According to the NASCET-Method the grade of stenosis in relation to the diameter of the ACI distal to the stenosis in the area of the parallel arterial wall is measured.
Time frame: approximately up to 3 months after Implantation
Postoperative bleeding
Retrospective evaluation of restenosis rate from information documented in the patient file: Report of any bleeding during postoperative course
Time frame: approximately up to 3 months after Implantation
Rate of Intraoperative stroke
Retrospective evaluation of stroke rate from information documented in the patient file: Report of any intraoperative stroke
Time frame: intraoperatively
Rate of postoperative stroke
Retrospective evaluation of stroke rate from information documented in the patient file: Report of any stroke during postoperative course
Time frame: approximately up to 3 months after Implantation
Rate of patch related infections
Retrospective evaluation of any patch related infections from information documented in the patient file: Report of any patch related infections during postoperative course
Time frame: approximately up to 3 months after Implantation
Rate of postoperative nerve lesions
Retrospective evaluation of nerve lesion rate from information documented in the patient file: Report of any postoperative nerve lesions postoperative course
Time frame: approximately up to 3 months after Implantation
Rate of postoperative pseudoaneurysm
Retrospective evaluation of pseudoaneurysm rate from information documented in the patient file: Report of any postoperative pseudoaneurysm during postoperative course
Time frame: approximately up to 3 months after Implantation
Primary and secondary patency rate
Retrospective evaluation of primary and secondary patency rate from information documented in the patient file during postoperative course
Time frame: approximately up to 3 months after Implantation
Freedom of re-intervention rate
Retrospective evaluation of re-intervention rate from information documented in the patient file: Report of any re-intervention during postoperative course
Time frame: approximately up to 3 months after Implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.